Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome
about
Successful management of Barth syndrome: a systematic review highlighting the importance of a flexible and multidisciplinary approachBarth syndrome.Tafazzin protein expression is associated with tumorigenesis and radiation response in rectal cancer: a study of Swedish clinical trial on preoperative radiotherapyTafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosisWhole Body Vibration Retards Progression of Atherosclerosis via Insulin-Like Growth Factor 1 in Apolipoprotein E-Deficient Mice.
P2860
Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome
@ast
Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome
@en
type
label
Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome
@ast
Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome
@en
prefLabel
Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome
@ast
Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome
@en
P2093
P2860
P356
P1476
Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome
@en
P2093
Christina D Schwindt Md
Cyril S Rakovski
Lori D Wilson
Sadeeka Al-Majid
P2860
P2888
P356
10.1186/1476-9255-9-25
P577
2012-06-21T00:00:00Z